These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5045357)

  • 1. Evaluation of mist tent therapy in cystic fibrosis using maximum expiratory flow volume curve.
    Motoyama EK; Gibson LE; Zigas CJ
    Pediatrics; 1972 Aug; 50(2):299-306. PubMed ID: 5045357
    [No Abstract]   [Full Text] [Related]  

  • 2. The measurement of fluid deposition in humans following mist tent therapy.
    Bau SK; Aspin N; Wood DE; Levison H
    Pediatrics; 1971 Oct; 48(4):605-12. PubMed ID: 5114748
    [No Abstract]   [Full Text] [Related]  

  • 3. Late effect of nocturnal mist tent therapy related to the severity of airway obstruction in children with cystic fibrosis.
    Bureau MA; McDougall DM; Beaudry PH; Belmonte MM
    Pediatrics; 1978 Jun; 61(6):842-6. PubMed ID: 673547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of nightly mist tent therapy for patients with cystic fibrosis.
    Chang N; Levison H; Cunningham K; Crozier DN; Grosett O
    Am Rev Respir Dis; 1973 Apr; 107(4):672-5. PubMed ID: 4697676
    [No Abstract]   [Full Text] [Related]  

  • 5. Mist tent therapy of the obstructive pulmonary lesion of cystic fibrosis.
    Matthews LW; Doershuk CF; Spector S
    Pediatrics; 1967 Feb; 39(2):176-85. PubMed ID: 6017955
    [No Abstract]   [Full Text] [Related]  

  • 6. "Spare the cough, spoil the airway:" back to the basics in airway clearance.
    Donahue M
    Pediatr Nurs; 2002; 28(2):107-11. PubMed ID: 11962175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Area under the maximum expiratory flow-volume curve--a sensitive parameter in the evaluation of airway patency.
    Zapletal A; Hladíková M; Chalupová J; Svobodová T; Vávrová V
    Respiration; 2008; 75(1):40-7. PubMed ID: 17299253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low level of bacterial contamination of mist tents used in home treatment of cystic fibrosis patients.
    Jakobsson B; Hjelte L; Nyström B
    J Hosp Infect; 2000 Jan; 44(1):37-41. PubMed ID: 10633052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of pulmonary function abnormalities in cystic fibrosis.
    Lamarre A; Reilly BJ; Bryan AC; Levison H
    Pediatrics; 1972 Aug; 50(2):291-8. PubMed ID: 5045356
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of the flutter device on pulmonary function studies among pediatric cystic fibrosis patients.
    Padman R; Geouque DM; Engelhardt MT
    Del Med J; 1999 Jan; 71(1):13-8. PubMed ID: 10024754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluid deposition in airways after mist tent therapy.
    Chadwick DL
    Pediatrics; 1972 Apr; 49(4):630-1. PubMed ID: 5013431
    [No Abstract]   [Full Text] [Related]  

  • 12. Chest physiotherapy with positive airway pressure: a pilot study of short-term effects on sputum clearance in patients with cystic fibrosis and severe airway obstruction.
    Placidi G; Cornacchia M; Polese G; Zanolla L; Assael BM; Braggion C
    Respir Care; 2006 Oct; 51(10):1145-53. PubMed ID: 17005060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home versus hospital intravenous antibiotic therapy for acute pulmonary exacerbations in children with cystic fibrosis.
    Nazer D; Abdulhamid I; Thomas R; Pendleton S
    Pediatr Pulmonol; 2006 Aug; 41(8):744-9. PubMed ID: 16779852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of bronchial obstruction with bi-level positive airway pressure and nebulization in patients with acute asthma.
    Brandao DC; Lima VM; Filho VG; Silva TS; Campos TF; Dean E; de Andrade AD
    J Asthma; 2009 May; 46(4):356-61. PubMed ID: 19484669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between spirometric indices and ambulatorial clinical checking of patients with cystic fibrosis].
    Rigillo N; Manca A; Mallardi A; Corrado R
    Pediatria (Napoli); 1982 Sep; 90(3):259-67. PubMed ID: 7155700
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of jet-type and ultrasonic nebulizers in mist tent therapy for cystic fibrosis.
    Doershuk CF; Matthews LW; Gillespie CT; Lough MD; Spector S
    Pediatrics; 1968 Apr; 41(4):723-32. PubMed ID: 5643980
    [No Abstract]   [Full Text] [Related]  

  • 17. Lung elastic recoil in cystic fibrosis.
    Mansell A; Dubrawsky C; Levison H; Bryan AC; Crozier DN
    Am Rev Respir Dis; 1974 Feb; 109(2):190-7. PubMed ID: 4811775
    [No Abstract]   [Full Text] [Related]  

  • 18. [Maximal expiratory flow rate and "circumscribed" forced vital capacity respiration. Normal values in children and adolescents and their importance in evaluation of airway obstruction].
    Zapletal A; Samánek M
    Cas Lek Cesk; 1974 Nov; 113(40):1225-32. PubMed ID: 4421241
    [No Abstract]   [Full Text] [Related]  

  • 19. The spectrum of cystic fibrosis. A study of pulmonary mechanics in 46 patients.
    Landau LI; Phelan PD
    Am Rev Respir Dis; 1973 Sep; 108(3):593-602. PubMed ID: 4745256
    [No Abstract]   [Full Text] [Related]  

  • 20. The immediate effect of physiotherapy and aerosol treatment on pulmonary function in children with cystic fibrosis.
    Kerrebijn KF; Veentjer R; Bonzet-vd Water E
    Eur J Respir Dis; 1982 Jan; 63(1):35-42. PubMed ID: 7067754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.